# Nephros Schedules First Quarter 2026 Financial Results Conference Call
Canonical URL: https://biopharmsignal.com/news/NEPH/nephros-schedules-first-quarter-2026-financial-results-conference-call-eb612ca2
Ticker: NEPH
Company: Nephros
Source: Nephros
Published: 2026-04-30 20:00 EST
## Summary

Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced th...

## Article Body
Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Thursday, May 07, 2026 after market close and will host a conference call that same day at 4:30pm ET.

Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-5285

Upon joining, please ask to be joined into the Nephros conference call.

An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page .

Alternatively, a replay of the call may be accessed until May 14, 2026 at 1-855-669-9658 or 1-412-317-0088 for international callers and entering replay access code: 1329051.

About Nephros Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within medical and commercial markets, offering both proactive and emergency solutions for water management.

For more information about Nephros, please visit us at nephros.com .

Investor Relations Contacts: Kirin Smith, President PCG Advisory, Inc. ksmith@pcgadvisory.com

Robert Banks, CEO Nephros, Inc. (201) 343-5202 x110 robert.banks@nephros.com
## Recent Company News
- 2026-07-20 11:00 EST — [Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET](https://biopharmsignal.com/news/NEPH/nephros-to-participate-in-the-health-wellness-longevity-virtual-conference-prese-04bc108f) — Source: Nephros
- 2026-07-06 11:00 EST — [Nephros Announces Inclusion in the Russell Microcap® Index](https://biopharmsignal.com/news/NEPH/nephros-announces-inclusion-in-the-russell-microcap-index-8f384e42) — Source: Nephros
- 2026-06-18 11:00 EST — [Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”](https://biopharmsignal.com/news/NEPH/nephros-to-host-virtual-investor-event-beyond-filtration-the-nephros-model-in-ac-6be1cdda) — Source: Nephros
- 2026-06-16 11:00 EST — [Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water](https://biopharmsignal.com/news/NEPH/nephros-positions-ultrafiltration-technology-as-a-solution-to-emerging-microplas-60dc48d7) — Source: Nephros
- 2026-05-07 20:05 EST — [Nephros Announces Financial Results for Quarter Ended March 31, 2026](https://biopharmsignal.com/news/NEPH/nephros-announces-financial-results-for-quarter-ended-march-31-2026-6679efc9) — Source: Nephros
## Related News
- 2026-07-29 20:05 EST — SERA — [SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026](https://biopharmsignal.com/news/SERA/sera-prognostics-announces-conference-call-and-webcast-of-second-quarter-fiscal--2a2c0c5a)
- 2026-07-29 20:05 EST — VKTX — [Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/VKTX/viking-therapeutics-reports-second-quarter-2026-financial-results-and-provides-c-2f09b8ce)
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)